Becton, Dickinson & Co.: Standardized Incubation and Imaging System Now Available to U.S. Clinical Microbiology Laboratories
February 18, 2020
February 18, 2020
FRANKLIN LAKES, New Jersey, Feb. 18 -- Becton, Dickinson and Co., a medical technology company, issued the following news release:
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that the BD Kiestra(TM) ReadA is device listed with the U.S. Food and Drug Administration (FDA). The BD Kiestra(TM) ReadA, which is available as a standalone instrument, helps improve operational efficiency in clinical microbiology laboratories by autom . . .
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that the BD Kiestra(TM) ReadA is device listed with the U.S. Food and Drug Administration (FDA). The BD Kiestra(TM) ReadA, which is available as a standalone instrument, helps improve operational efficiency in clinical microbiology laboratories by autom . . .